首页> 外文学位 >Ten-year survival of patients with aids receiving aniretroviral therapy in Haiti and lessons learned from the survivors
【24h】

Ten-year survival of patients with aids receiving aniretroviral therapy in Haiti and lessons learned from the survivors

机译:在海地接受抗逆转录病毒治疗的辅助工具患者的十年生存期以及从幸存者那里获得的经验教训

获取原文
获取原文并翻译 | 示例

摘要

Background: Long-term outcomes of antiretroviral therapy (ART) in resource-poor settings are unknown. Understanding the psychosocial and contextual factors that enable patients living with HIV/AIDS to survive at least 10 years after the initiation of ART is necessary. Given Haiti's unique and fragile political and economic infrastructure, we describe the 10-year outcomes, characteristics of the first cohort of patients receiving ART in Haiti, and the experience of the 10-year survivors in the following chapters.;Methods: Data from 910 patients, age ≥ 13 years, who initiated ART from 2003-2004 were included. Lost-to follow-up (LTF) was defined as no clinic/pharmacy visit within 180 days of the date of censor. Kaplan Meier, contact tracing with inverse probability weighting, and multiple imputation methods were used to estimate survival. Cox modeling and logistic regression were used to identify characteristics associated with survival. Additionally, individual audiotaped in-depth interviews that lasted 45 to 60 minutes using a semi-structured open-ended format were conducted with 25 participants who survived at least 10 years with AIDS, in between January 2015 and August 2015. Grounded theory approach was used for data collection and analysis. Each interview was then transcribed verbatim and back-translated from Creole to English. Questions focused on understanding how participants survived in the midst of challenges faced by the 10-year survivors since starting ART, coping strategies used to overcome those challenges, accomplishments that they made during those 10 years, and their hopes.;Results: Among 910 adults who initiated ART, 55% were female, median age was 38 years, and median CD4+ was 131 cells/uL (IQR 57-212). Ten years after ART initiation, 53% were alive, 27% dead, 12% were LTF, and 8% transferred care. Ten-year survival estimates ranged from 63--71%. Forty-two percent of deaths occurred in the first 6 months; characteristics associated with early death were being male, age > 50 years, low weight, WHO Stage III/IV, and baseline TB. Characteristics associated with death after 6 months were age > 50 years, income < $1 per day, low weight, and low adherence. Among 10-year survivors, 58% were female, median age was 49 years (IQR43-55), and median CD4+ was 541 cells/uL. Seventy-three percent remained on first-line therapy and 38% had a chronic non-communicable disease. We integrated our core findings into an explanatory framework. The 25 participants described stressors aside from HIV, including poverty, sociopolitical challenges and stigmatization that are counterbalanced with positive outlook and the fact of having a goal. Psychosocial factors like caring for one's child, spirituality and faith, the role of providers and adherence to antiretroviral helped them to look past the disease and have another meaning to theirs lives in order to survive the 10 years of ART.;Conclusion: The 10-year survival of patients with AIDS receiving ART in Haiti is approximately 70%, which demonstrates the long-term sustainability of international efforts to provide ART in resource-poor settings. Aside the devastating health impacts of HIV itself, there was an underlying current of resilience, hope, and the desire to live. As described in the second study, women with children wanted to work and support their children's education. This study provides a portrait of Haiti that is not defined by death or hopelessness.
机译:背景:资源贫乏地区抗逆转录病毒疗法(ART)的长期结果尚不清楚。必须了解使艾滋病毒/艾滋病患者能够在接受抗逆转录病毒治疗后至少存活10年的心理社会和背景因素。鉴于海地独特而脆弱的政治和经济基础设施,我们在以下各章中介绍了10年的结局,海地首批接受抗逆转录病毒疗法的患者的特征以及10年幸存者的经验。方法:910年的数据纳入从2003年至2004年开始抗逆转录病毒疗法的年龄≥13岁的患者。失访(LTF)的定义是在审查日期后180天内没有诊所/药房就诊。卡普兰·迈耶(Kaplan Meier),具有逆概率加权的接触跟踪以及多种插补方法被用于估计生存率。使用Cox建模和逻辑回归来确定与生存相关的特征。此外,在2015年1月至2015年8月之间,对25名在艾滋病中存活至少10年的参与者进行了使用半结构式开放式访谈的,持续45至60分钟的深度录音采访,采用了扎根理论方法。用于数据收集和分析。然后,将每个访谈逐字记录下来,并从克里奥尔语反译为英语。问题的重点是了解参与者自开始接受抗逆转录病毒疗法以来的十年生存者所面临的挑战中如何生存,用于克服这些挑战的应对策略,他们在那十年中取得的成就以及他们的希望。结果:910名成年人中发起抗逆转录病毒疗法的女性占55%,中位年龄为38岁,中位CD4 +为131个细胞/微升(IQR 57-212)。开展抗逆转录病毒治疗十年后,还活着的有53%,死亡的有27%,LTF的有12%,转移的护理有8%。十年生存率估计为63--71%。 42%的死亡发生在头6个月内;与早期死亡相关的特征是男性,年龄> 50岁,体重轻,WHO III / IV期和基线结核病。与6个月后死亡相关的特征是年龄> 50岁,每天收入<$ 1,体重轻和依从性低。在10年存活者中,女性占58%,中位年龄为49岁(IQR43-55),中位CD4 +为541细胞/ uL。一线治疗仍占73%,而慢性非传染性疾病占38%。我们将我们的核心发现整合到一个解释性框架中。 25位参与者描述了除了艾滋病毒之外的压力源,包括贫困,社会政治挑战和污名化,这些压力与积极的看法和有目标的事实相抵消。心理社会因素,例如照顾孩子,灵性和信仰,提供者的作用以及对抗逆转录病毒的依从,使他们能够越过疾病,对自己的生活具有另一种意义,以便在ART的10年中生存下来;结论:10-在海地接受抗逆转录病毒治疗的艾滋病患者的一年生存率约为70%,这表明了国际上在资源贫乏地区提供抗逆转录病毒疗法的努力的长期可持续性。除了艾滋病毒本身对健康的破坏性影响外,还存在潜在的复原力,希望和生活欲望。如第二项研究所述,有子女的妇女想工作并支持子女的教育。这项研究提供了海地的肖像,它不是由死亡或绝望定义的。

著录项

  • 作者

    Pierre, Samuel.;

  • 作者单位

    Weill Medical College of Cornell University.;

  • 授予单位 Weill Medical College of Cornell University.;
  • 学科 Health sciences.;Epidemiology.;Caribbean studies.
  • 学位 M.S.
  • 年度 2016
  • 页码 55 p.
  • 总页数 55
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号